Description
Developed by iomics Biosciences, the Inspirer DX Analyzer harnesses the power of breakthrough single-molecule digital immunoassay technology. By delivering 1,000 times greater sensitivity than traditional ELISA methods, this platform enables the precise quantification of target proteins at ultra-low concentrations—down to the femtogram per milliliter (fg/mL) level. This technological leap facilitates the identification of pathological biomarkers 10–20 years before clinical symptoms manifest, empowering a new era of early intervention.
Key Features
- Unrivaled Sensitivity: With a detection limit reaching 2.5 fg/mL, the system enables early Alzheimer’s diagnosis via simple blood samples, providing a practical and non-invasive alternative to Cerebrospinal Fluid (CSF) collection.
- Intelligent Ecosystem: The seamless integration of high-density microfluidic biochips, ultra-high-resolution imaging, and AI-driven recognition algorithms ensures unmatched accuracy and eliminates manual errors.
- Optimized Workflow: Requiring only a minimal 25 μL sample volume and delivering results in just 20–30 minutes, it allows clinicians and researchers to make rapid, data-driven decisions.
- Versatile Sample Compatibility: Fully supports diverse sample types, including Plasma, CSF, and others.
- Multidisciplinary Applications: A comprehensive solution for Neurology, Cardiovascular diseases, Inflammation & Immunity, Oncology research, and Drug R&D.
- Compact & Efficient Design: Precision engineering in a space-saving frame (638 x 740 x 658 mm).